Hosted on MSN1mon
Environmentally Friendlier COPD Inhaler May Also Be More Effective
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere ... Eligible patients had COPD, were ages 40 or older, and were new initiators of these inhalers from 2021 to 2023.
pharmaphorum2d
Smart sensor cleared for use with AZ asthma, COPD inhalers
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...
The Financial Express12d
AstraZeneca’s Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...